According to DelveInsight’s analysis, the chronic refractory cough market size is expected to increase due to an increase in disease prevalence, the growth in the market of currently approved products, and the expected launch of […]
Tag: Pharmaceuticals
John Elway Teams Up with Endo to Share Update on Dupuytren’s Contracture and Treatment with XIAFLEX® (collagenase clostridium histolyticum)
MALVERN, Pa., Nov. 20, 2024 /PRNewswire/ — Endo, Inc. (“Endo”) (OTCQX: NDOI) announced today that John Elway will share an update about his Dupuytren’s contracture patient journey, including his treatment with XIAFLEX® (collagenase clostridium histolyticum) […]
BioLineRx to Report Third Quarter 2024 Results on November 25, 2024
Management to Hold Conference Call at 8:30 a.m. EST TEL AVIV, Israel, Nov. 20, 2024 /PRNewswire/ — BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare […]
Flagship Pioneering Announces Two New Agreements with Ampersand Biomedicines and Montai Therapeutics Under its Strategic Partnership with Pfizer
Ampersand’s AND™ Platform will be used to identify programmed biologics for the treatment of obesity-related targets Montai’s CONECTA™ AI platform will be used to identify small molecules directed to a potential Non-Small Cell Lung Cancer-related target […]
Nagase Viita lanzará el excipiente farmacéutico inyectable «SUCROSE SG» en 2025
OKAYAMA, Japón, 20 de noviembre de 2024 /PRNewswire/ — Nagase Viita Co., Ltd., miembro del Grupo NAGASE con sede en Okayama (Japón), se dispone a ampliar la línea de SOLBIOTE (TM), excipientes farmacéuticos a base […]